5-112780935-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000038.6(APC):​c.645+32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0837 in 1,372,594 control chromosomes in the GnomAD database, including 5,376 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.067 ( 417 hom., cov: 32)
Exomes 𝑓: 0.086 ( 4959 hom. )

Consequence

APC
NM_000038.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.975

Publications

14 publications found
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
  • classic or attenuated familial adenomatous polyposis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • desmoid tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • familial adenomatous polyposis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • gastric adenocarcinoma and proximal polyposis of the stomach
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • APC-related attenuated familial adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Turcot syndrome with polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 5-112780935-C-T is Benign according to our data. Variant chr5-112780935-C-T is described in ClinVar as Benign. ClinVar VariationId is 218001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0915 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APCNM_000038.6 linkc.645+32C>T intron_variant Intron 6 of 15 ENST00000257430.9 NP_000029.2 P25054-1Q4LE70

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APCENST00000257430.9 linkc.645+32C>T intron_variant Intron 6 of 15 5 NM_000038.6 ENSP00000257430.4 P25054-1

Frequencies

GnomAD3 genomes
AF:
0.0674
AC:
10248
AN:
151976
Hom.:
419
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0319
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.0569
Gnomad ASJ
AF:
0.0686
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0909
Gnomad FIN
AF:
0.0695
Gnomad MID
AF:
0.131
Gnomad NFE
AF:
0.0934
Gnomad OTH
AF:
0.0685
GnomAD2 exomes
AF:
0.0757
AC:
16861
AN:
222672
AF XY:
0.0811
show subpopulations
Gnomad AFR exome
AF:
0.0300
Gnomad AMR exome
AF:
0.0391
Gnomad ASJ exome
AF:
0.0769
Gnomad EAS exome
AF:
0.000577
Gnomad FIN exome
AF:
0.0792
Gnomad NFE exome
AF:
0.0959
Gnomad OTH exome
AF:
0.0832
GnomAD4 exome
AF:
0.0857
AC:
104575
AN:
1220500
Hom.:
4959
Cov.:
17
AF XY:
0.0872
AC XY:
53800
AN XY:
616838
show subpopulations
African (AFR)
AF:
0.0307
AC:
853
AN:
27814
American (AMR)
AF:
0.0411
AC:
1758
AN:
42798
Ashkenazi Jewish (ASJ)
AF:
0.0746
AC:
1831
AN:
24550
East Asian (EAS)
AF:
0.000352
AC:
13
AN:
36982
South Asian (SAS)
AF:
0.104
AC:
8190
AN:
78922
European-Finnish (FIN)
AF:
0.0793
AC:
4167
AN:
52560
Middle Eastern (MID)
AF:
0.100
AC:
535
AN:
5330
European-Non Finnish (NFE)
AF:
0.0923
AC:
82988
AN:
899166
Other (OTH)
AF:
0.0809
AC:
4240
AN:
52378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
4569
9138
13708
18277
22846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2732
5464
8196
10928
13660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0674
AC:
10257
AN:
152094
Hom.:
417
Cov.:
32
AF XY:
0.0669
AC XY:
4974
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.0321
AC:
1332
AN:
41484
American (AMR)
AF:
0.0569
AC:
869
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0686
AC:
238
AN:
3470
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5184
South Asian (SAS)
AF:
0.0906
AC:
437
AN:
4824
European-Finnish (FIN)
AF:
0.0695
AC:
734
AN:
10564
Middle Eastern (MID)
AF:
0.140
AC:
41
AN:
292
European-Non Finnish (NFE)
AF:
0.0934
AC:
6350
AN:
67970
Other (OTH)
AF:
0.0673
AC:
142
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
481
961
1442
1922
2403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0757
Hom.:
177
Bravo
AF:
0.0639
Asia WGS
AF:
0.0310
AC:
110
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 15, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial adenomatous polyposis 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.0
DANN
Benign
0.75
PhyloP100
-0.97
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2909961; hg19: chr5-112116632; COSMIC: COSV57325227; COSMIC: COSV57325227; API